Everyday Health on MSN
What does treatment for ANCA-associated vasculitis (AAV) look like today?
Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.
Chronic lung disease is associated with a higher risk for infection in patients with ANCA-associated vasculitis during both induction and maintenance treatment.
Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Most children with ANCA-associated vasculitis had active ...
While a diagnosis of antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, may seem daunting, it’s important to know that this chronic autoimmune disorder is no longer the ...
In patients with ANCA-associated vasculitis (AAV), double seropositivity for MPO-ANCA and PR3-ANCA is linked to worse remission rates compared with either AAV type alone. Idiopathic ANCA-associated ...
Antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, causes inflammation of the blood vessels and can affect many parts of the body, including multiple organs. Because of this, ...
In a study of patients with concomitant ANCA-associated vasculitis (AAV) and inflammatory bowel disease (IBD), IBD preceded AAV in 79.4% of cases. Investigators have reported a possible pathogenic ...
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) ...
In this video, Craig Gordon, MD, nephrologist at Tufts Medical Center and associate professor of medicine at Tufts University School of Medicine, discusses the treatment options in this case of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results